Cerebrospinal fluid inflammation during OKT3 therapy.
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D002555:Cerebrospinal Fluid / Q000166:cytology*; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007249:Inflammation / Q000139:chemically induced; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged
D000911:Antibodies, Monoclonal